{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:43Z","timestamp":1792785103655,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Major Project for Biological Breeding","award":["2023ZD04046"],"award-info":[{"award-number":["2023ZD04046"]}]},{"name":"Shenzhen Outstanding Talents Training Fund","award":["202102"],"award-info":[{"award-number":["202102"]}]},{"name":"National Natural Science Foundation of China","award":["32202647"],"award-info":[{"award-number":["32202647"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Capacity Building Project of the Key Technology Platform, SIBPT","award":["PT2025-03-01"],"award-info":[{"award-number":["PT2025-03-01"]}]},{"name":"Innovation Promotion Program of NHC and Shanghai Key Labs, SIBPT","award":["RC2025-01"],"award-info":[{"award-number":["RC2025-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Syst Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Type V CRISPR-Cas12 systems evolved from transposon-encoded TnpB proteins, with type V-U4 nucleases (Cas12n) as evolutionary intermediates linking TnpB to larger type V effectors. Despite their compact size, most Cas12n orthologs, including\n                    <jats:italic>Corynebacterium glutamicum<\/jats:italic>\n                    Cas12n (CgCas12n), exhibit low genome-editing activity in mammalian cells. Here, we engineered CgCas12n using an arginine enrichment strategy, generating a variant with approximately 60-fold enhanced editing efficiency. Concurrently, we optimized the sgRNA scaffold to reduce its size without compromising activity. These improvements were combined to establish an enhanced CgCas12n system (eCgCas12n) that enables efficient mammalian genome editing. We further adapted this system for base editing by constructing a cytosine base editor (eCgCas12n-CBE) that mediates efficient C-to-T conversion. As proof of concept, eCgCas12n-CBE introduced a premature stop codon into the Dmd gene, reducing dystrophin expression and impairing myogenic differentiation. AAV9-mediated delivery of eCgCas12n-CBE into mouse skeletal muscle demonstrated its in vivo editing capability. Collectively, this work establishes a robust engineering strategy to enhance compact Cas12n nucleases and provides an efficient genome- and base-editing platform for functional genetic studies.\n                  <\/jats:p>","DOI":"10.1038\/s44320-026-00248-z","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:29:51Z","timestamp":1790436591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering a compact CgCas12n platform for efficient genome and base editing in mammalian cells"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3333-2121","authenticated-orcid":false,"given":"Bowen","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-5012","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7812-6266","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-1247","authenticated-orcid":false,"given":"Xingxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-3898","authenticated-orcid":false,"given":"Kui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"248_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416331","volume":"12","author":"M Alariqi","year":"2025","unstructured":"Alariqi M, Ramadan M, Yu L, Hui F, Hussain A, Zhou X, Yu Y, Zhang X, Jin S (2025) Enhancing specificity, precision, accessibility, flexibility, and safety to overcome traditional CRISPR\/Cas editing challenges and shape future innovations. Adv Sci 12:e2416331","journal-title":"Adv Sci"},{"key":"248_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ymthe.2023.11.013","volume":"32","author":"IW Badon","year":"2024","unstructured":"Badon IW, Oh Y, Kim HJ, Lee SH (2024) Recent application of CRISPR-Cas12 and OMEGA system for genome editing. Mol Ther 32:32\u201343","journal-title":"Mol Ther"},{"key":"248_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26469-4","volume":"12","author":"G Bigelyte","year":"2021","unstructured":"Bigelyte G, Young JK, Karvelis T, Budre K, Zedaveinyte R, Djukanovic V, Van Ginkel E, Paulraj S, Gasior S, Jones S et al (2021) Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells. Nat Commun 12:6191","journal-title":"Nat Commun"},{"key":"248_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","volume":"67","author":"P Billon","year":"2017","unstructured":"Billon P, Bryant EE, Joseph SA, Nambiar TS, Hayward SB, Rothstein R, Ciccia A (2017) CRISPR-mediated base editing enables efficient disruption of eukaryotic genes through induction of STOP codons. Mol Cell 67:1068\u20131079.e1064","journal-title":"Mol Cell"},{"key":"248_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2501292122","volume":"122","author":"L Chen","year":"2025","unstructured":"Chen L, Zhou X, Huang C, Zhang Y, Xin C, Hong J, Wang Y (2025) Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage. Proc Natl Acad Sci USA 122:e2501292122","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR6","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.molcel.2023.06.014","volume":"83","author":"W Chen","year":"2023","unstructured":"Chen W, Ma J, Wu Z, Wang Z, Zhang H, Fu W, Pan D, Shi J, Ji Q (2023) Cas12n nucleases, early evolutionary intermediates of type V CRISPR, comprise a distinct family of miniature genome editors. Mol Cell 83:2768\u20132780.e2766","journal-title":"Mol Cell"},{"key":"248_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA et al (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339:819\u2013823","journal-title":"Science"},{"key":"248_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Prim 7:13","journal-title":"Nat Rev Dis Prim"},{"key":"248_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrg3460","volume":"14","author":"RJ Fairclough","year":"2013","unstructured":"Fairclough RJ, Wood MJ, Davies KE (2013) Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet 14:373\u2013378","journal-title":"Nat Rev Genet"},{"key":"248_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61290-3","volume":"16","author":"W Fu","year":"2025","unstructured":"Fu W, Ma J, Wang Z, Tang N, Pan D, Su M, Wu Z, Gan J, Ji Q (2025) Mechanisms and engineering of a miniature type V-N CRISPR-Cas12 effector enzyme. Nat Commun 16:5667","journal-title":"Nat Commun"},{"key":"248_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"key":"248_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aav4294","volume":"362","author":"LB Harrington","year":"2018","unstructured":"Harrington LB, Burstein D, Chen JS, Paez-Espino D, Ma E, Witte IP, Cofsky JC, Kyrpides NC, Banfield JF, Doudna JA (2018) Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362:839\u2013842","journal-title":"Science"},{"key":"248_CR13","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1093\/nar\/gkaa208","volume":"48","author":"T Karvelis","year":"2020","unstructured":"Karvelis T, Bigelyte G, Young JK, Hou Z, Zedaveinyte R, Budre K, Paulraj S, Djukanovic V, Gasior S, Silanskas A et al (2020) PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage. Nucleic Acids Res 48:5016\u20135023","journal-title":"Nucleic Acids Res"},{"key":"248_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41586-021-04058-1","volume":"599","author":"T Karvelis","year":"2021","unstructured":"Karvelis T, Druteika G, Bigelyte G, Budre K, Zedaveinyte R, Silanskas A, Kazlauskas D, Venclovas \u010c, Siksnys V (2021) Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. Nature 599:692\u2013696","journal-title":"Nature"},{"key":"248_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41587-021-01009-z","volume":"40","author":"DY Kim","year":"2022","unstructured":"Kim DY, Lee JM, Moon SB, Chin HJ, Park S, Lim Y, Kim D, Koo T, Ko JH, Kim YS (2022) Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nat Biotechnol 40:94\u2013102","journal-title":"Nat Biotechnol"},{"key":"248_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-018-0011-0","volume":"37","author":"BP Kleinstiver","year":"2019","unstructured":"Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, Welch MM, Horng JE, Malagon-Lopez J, Scarf\u00f2 I et al (2019) Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol 37:276\u2013282","journal-title":"Nat Biotechnol"},{"key":"248_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420\u2013424","journal-title":"Nature"},{"key":"248_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37829-7","volume":"14","author":"X Kong","year":"2023","unstructured":"Kong X, Zhang H, Li G, Wang Z, Kong X, Wang L, Xue M, Zhang W, Wang Y, Lin J et al (2023) Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing. Nat Commun 14:2046","journal-title":"Nat Commun"},{"key":"248_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60124-6","volume":"16","author":"S Ma","year":"2025","unstructured":"Ma S, Liao K, Chen K, Cheng T, Yang X, Chen P, Li S, Li M, Zhang X, Zhang Y et al (2025) hpCasMINI: an engineered hypercompact CRISPR-Cas12f system with boosted gene editing activity. Nat Commun 16:5001","journal-title":"Nat Commun"},{"key":"248_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339:823\u2013826","journal-title":"Science"},{"key":"248_CR21","doi-asserted-by":"publisher","first-page":"aaf8729","DOI":"10.1126\/science.aaf8729","volume":"353","author":"K Nishida","year":"2016","unstructured":"Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY et al (2016) Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353:aaf8729","journal-title":"Science"},{"key":"248_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.abb1400","volume":"369","author":"P Pausch","year":"2020","unstructured":"Pausch P, Al-Shayeb B, Bisom-Rapp E, Tsuchida CA, Li Z, Cress BF, Knott GJ, Jacobsen SE, Banfield JF, Doudna JA (2020) CRISPR-Cas\u03a6 from huge phages is a hypercompact genome editor. Science 369:333\u2013337","journal-title":"Science"},{"key":"248_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41586-021-04030-z","volume":"599","author":"I Querques","year":"2021","unstructured":"Querques I, Schmitz M, Oberli S, Chanez C, Jinek M (2021) Target site selection and remodelling by type V CRISPR-transposon systems. Nature 599:497\u2013502","journal-title":"Nature"},{"key":"248_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1126\/science.abq7220","volume":"376","author":"G Schuler","year":"2022","unstructured":"Schuler G, Hu C, Ke A (2022) Structural basis for RNA-guided DNA cleavage by IscB-\u03c9RNA and mechanistic comparison with Cas9. Science 376:1476\u20131481","journal-title":"Science"},{"key":"248_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84\u201387","journal-title":"Science"},{"key":"248_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64562-0","volume":"16","author":"Z Song","year":"2025","unstructured":"Song Z, Guo J, Fan Z, Huang S, Li G, Zhao Z, Chen B, Huang S, Zheng W, Wei Y et al (2025) Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform. Nat Commun 16:9499","journal-title":"Nat Commun"},{"key":"248_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/science.aax9181","volume":"365","author":"J Strecker","year":"2019","unstructured":"Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS, Koonin EV, Zhang F (2019) RNA-guided DNA insertion with CRISPR-associated transposases. Science 365:48\u201353","journal-title":"Science"},{"key":"248_CR28","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molcel.2020.11.035","volume":"81","author":"SN Takeda","year":"2021","unstructured":"Takeda SN, Nakagawa R, Okazaki S, Hirano H, Kobayashi K, Kusakizako T, Nishizawa T, Yamashita K, Nishimasu H, Nureki O (2021) Structure of the miniature type V-F CRISPR-Cas effector enzyme. Mol Cell 81:558\u2013570.e553","journal-title":"Mol Cell"},{"key":"248_CR29","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41586-024-08310-2","volume":"637","author":"L Wan","year":"2025","unstructured":"Wan L, Ge X, Xu Q, Huang G, Yang T, Campbell KP, Yan Z, Wu J (2025) Structure and assembly of the dystrophin glycoprotein complex. Nature 637:1252\u20131260","journal-title":"Nature"},{"key":"248_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111418","volume":"40","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang Y, Pan D, Yu H, Zhang Y, Chen W, Li F, Wu Z, Ji Q (2022) Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease. Cell Rep 40:111418","journal-title":"Cell Rep"},{"key":"248_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-024-07598-4","volume":"631","author":"T Wiegand","year":"2024","unstructured":"Wiegand T, Hoffmann FT, Walker MWG, Tang S, Richard E, Le HC, Meers C, Sternberg SH (2024) TnpB homologues exapted from transposons are RNA-guided transcription factors. Nature 631:439\u2013448","journal-title":"Nature"},{"key":"248_CR32","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1016\/j.molcel.2022.11.003","volume":"82","author":"WY Wu","year":"2022","unstructured":"Wu WY, Mohanraju P, Liao C, Adiego-P\u00e9rez B, Creutzburg SCA, Makarova KS, Keessen K, Lindeboom TA, Khan TS, Prinsen S et al (2022) The miniature CRISPR-Cas12m effector binds DNA to block transcription. Mol Cell 82:4487\u20134502.e4487","journal-title":"Mol Cell"},{"key":"248_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41589-021-00868-6","volume":"17","author":"Z Wu","year":"2021","unstructured":"Wu Z, Zhang Y, Yu H, Pan D, Wang Y, Wang Y, Li F, Liu C, Nan H, Chen W et al (2021) Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat Chem Biol 17:1132\u20131138","journal-title":"Nat Chem Biol"},{"key":"248_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41589-024-01706-1","volume":"21","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Li G, Han D, Wang H, Yao M, Ma T, Zhou J, Zhang Y, Zhang X, He B et al (2025) Engineered IscB-\u03c9RNA system with expanded target range for base editing. Nat Chem Biol 21:100\u2013108","journal-title":"Nat Chem Biol"},{"key":"248_CR35","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","volume":"81","author":"X Xu","year":"2021","unstructured":"Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, Qi LS (2021) Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol Cell 81:4333\u20134345.e4334","journal-title":"Mol Cell"},{"key":"248_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aav7271","volume":"363","author":"WX Yan","year":"2019","unstructured":"Yan WX, Hunnewell P, Alfonse LE, Carte JM, Keston-Smith E, Sothiselvam S, Garrity AJ, Chong S, Makarova KS, Koonin EV et al (2019) Functionally diverse type V CRISPR-Cas systems. Science 363:88\u201391","journal-title":"Science"},{"key":"248_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41594-020-0499-0","volume":"27","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li Z, Xiao R, Chang L (2020) Mechanisms for target recognition and cleavage by the Cas12i RNA-guided endonuclease. Nat Struct Mol Biol 27:1069\u20131076","journal-title":"Nat Struct Mol Biol"}],"container-title":["Molecular Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-026-00248-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44320-026-00248-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-026-00248-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:29:52Z","timestamp":1790436592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44320-026-00248-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":37,"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1038\/s44320-026-00248-z","relation":{},"ISSN":["1744-4292"],"issn-type":[{"value":"1744-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lei Huang is an employee of Agsino GenSources Co., Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}